The Challenge
Physician investors can often lose money on medtech startups if they rely solely on personal relationships and limited deal flow instead of professional due diligence. With 30-60% of early-stage investments failing, most doctors are essentially gambling with their capital while missing the best opportunities that never reach traditional medical conferences or trade shows.
Key Insights
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
